Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study
Articolo
Data di Pubblicazione:
2015
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
antiretroviral therapy; cancer; HIV; risk; Adult; Antiretroviral Therapy, Highly Active; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Male; Middle Aged; Neoplasms; Prospective Studies; Protease Inhibitors; Reverse Transcriptase Inhibitors; Risk Assessment; Infectious Diseases; Pharmacology (medical); Medicine (all)
Elenco autori:
Bruyand, Mathias; Ryom, Lene; Shepherd, Leah; Fatkenheuer, Gerd; Grulich, Andrew; Reiss, Peter; De Wit, Stéphane; Darminio Monforte, Antonella; Furrer, Hansjakob; Pradier, Christian; Lundgren, Jens; Sabin, Caroline; QUIROS ROLDAN, Maria Eugenia
Link alla scheda completa:
Pubblicato in: